{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-360059","form_type":"8-K","ticker":"HOWL","cik":"0001785530","company_name":"Werewolf Therapeutics, Inc.","filed_at":"2026-08-21T13:10:29+00:00","discovered_at":"2026-08-21T13:12:01.604656+00:00","generated_at":"2026-08-21T13:12:09.717083+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Werewolf to merge with Ambros in reverse merger; Ambros valued at $500M, PIPE of $150M","bullets":["Merger Sub to merge into Ambros; Ambros stockholders to own ~71.7% of combined company; Werewolf pre-merger holders ~6.8%.","Concurrent PIPE financing of $150M from qualified investors; proceeds condition to close; implies Werewolf valuation $47.5M.","Werewolf stockholders get CVRs for legacy WTX-124 and WTX-330 assets; no assurance of payments.","Termination fees: $20M payable by Ambros in certain circumstances; $1.9M payable by Werewolf.","Transaction requires stockholder approvals, S-4 filing, Nasdaq listing, and net cash condition; expected close not specified."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-360059","json":"https://secwatch.observer/filing/0001193125-26-360059.json","markdown":"https://secwatch.observer/filing/0001193125-26-360059.md","text":"https://secwatch.observer/filing/0001193125-26-360059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1785530/000119312526360059/0001193125-26-360059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1785530/000119312526360059/d102535d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-21T13:12:09.717083+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}